Amlodipine maximum dose 20 mg
Pro Research Analysisby 
Searched over 200M research papers
Maximum Dose of Amlodipine: Insights from Research
Introduction to Amlodipine and Its Usage
Amlodipine is a widely used calcium channel blocker prescribed for the treatment of hypertension and angina. It works by relaxing blood vessels, allowing blood to flow more easily, and reducing the workload on the heart. The standard dosing of amlodipine typically ranges from 2.5 mg to 10 mg per day, but there are discussions and studies around the potential for higher doses, such as 20 mg, particularly in combination therapies.
Efficacy and Safety of Amlodipine in Hypertension
Standard Dosing and Blood Pressure Control
Studies have shown that amlodipine is effective in reducing blood pressure in patients with mild to moderate hypertension. For instance, a study involving 30 patients demonstrated significant reductions in both systolic and diastolic blood pressure with doses ranging from 2.5 mg to 10 mg daily. The study also noted that amlodipine was well tolerated, with minimal side effects such as slight ankle edema in a few patients.
Combination Therapies
Combination therapies involving amlodipine have been explored to enhance efficacy and reduce side effects. For example, a study comparing amlodipine 5 mg/benazepril 20 mg with monotherapies found that the combination was more effective in reducing diastolic blood pressure and had a higher responder rate. Additionally, the combination therapy was associated with fewer instances of edema compared to amlodipine alone.
Pharmacokinetic Studies of Higher Doses
Fixed-Dose Combinations
Several studies have investigated the pharmacokinetics and safety of fixed-dose combinations (FDCs) involving amlodipine at higher doses. For instance, a study on a FDC of amlodipine 10 mg/olmesartan 40 mg/rosuvastatin 20 mg found that the pharmacokinetic profiles were bioequivalent to the co-administration of the individual drugs, suggesting that higher doses in combination are feasible and safe. Another study confirmed the bioequivalence of a FDC of amlodipine 5 mg/valsartan 160 mg/atorvastatin 20 mg with separate formulations, supporting the use of higher doses in combination therapies.
Non-Concurrent Dosing
Research has also explored the impact of non-concurrent dosing to mitigate potential drug interactions. A study found that non-concurrent dosing of amlodipine and simvastatin reduced the pharmacokinetic interaction between the two drugs, suggesting a safer approach for patients requiring multiple medications.
Clinical Implications and Conclusion
The research indicates that while the standard maximum dose of amlodipine is 10 mg per day, higher doses, particularly in combination therapies, can be effective and safe. Studies have shown that fixed-dose combinations involving higher doses of amlodipine are bioequivalent to separate administrations and can provide enhanced blood pressure control with manageable side effects . Non-concurrent dosing strategies may further improve safety profiles for patients on multiple medications.
In conclusion, while the maximum dose of amlodipine as a monotherapy remains at 10 mg, higher doses in combination therapies are supported by research, offering a viable option for patients with complex treatment needs.
Sources and full results
Most relevant research papers on this topic